Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Fosun Pharma, WuXi PharmaTech and two equity investors...
Suzhou NeuPharma has begun a Phase I clinical trial of...
Innovent Biologics of Suzhou, China and Eli Lilly...
BeiGene, a Beijing biopharma, filed to raise $100 million...
Hanmi Pharma of South Korea announced its fourth major...
The 8th annual ChinaBio® Partnering Forum 2016 life...
"China biotech is hot" was the opinion of prominent...
Innovent Biologics, a fast-growing Suzhou biotech, has...
Pfizer started construction of a $350 million Global...
TenNor Therapeutics of Suzhou announced a $25 million...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
